Details of the Drug Reposition

General Information of This Drug (ID: DM9DR13)

• Drug Name: PCAR-019 (DM9DR13)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

5 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Follicular lymphoma	DISVEUR6	2A80	Phase 1/2	[1]
Diffuse large B-cell lymphoma	DISSACK3	2A81	Phase 1/2	[1]
Chronic lymphocytic leukaemia	DISEXWC3	2A82.0	Phase 1/2	[1]
Mantle cell lymphoma	DISFREOV	2A85.5	Phase 1/2	[1]
Acute lymphocytic leukaemia	DISPX75S	2B33.3	Phase 1/2	[1]

References

• [1] ClinicalTrials.gov (NCT02819583) CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma